| Followers | 62 |
| Posts | 3433 |
| Boards Moderated | 0 |
| Alias Born | 08/11/2015 |
Tuesday, December 22, 2020 4:07:42 PM
$KOAN all set up per 8K “The Company has signed and announced definitive agreements with various partners to execute on our overall business strategy. Our partner Vertosa is expected to develop our unique formulations through its advanced nano-emulsification process, the Hive Laboratory is expected to assemble, package and distribute our products and Way To Blue is expected to actively market and deliver social media channels to the California market.”
Recent KOAN News
- Apollo Biowellness, Inc., Update of Take-Over by MedwellAI, Inc. • Newsfile • 04/08/2026 01:30:00 PM
- MedWell Ai Executes Letter Of Intent To Create America's First Vertically Integrated Regenerative Wellness Eco-System • GlobeNewswire Inc. • 02/10/2026 03:08:32 PM
- Apollo Biowellness Executes Letter Of Intent with Medwell AI, Inc. • Newsfile • 02/10/2026 02:30:00 PM
- Apollo Biowellness, Inc., Announces Termination of Distribution Agreement with Revive Regenerative, Inc. • Newsfile • 02/06/2026 02:30:00 PM
- Apollo Biowellness, Inc., Announces Expiration of Letter of Intent, Negotiations Continue • Newsfile • 01/07/2026 02:30:00 PM
- Apollo Biowellness, Inc., Corporate Status and Merger Update • Newsfile • 10/29/2025 01:30:00 PM
- Apollo Biowellness, Inc., Merger Update • Newsfile • 10/09/2025 06:48:00 PM
- Apollo Biowellness, Inc., Re-Engages GSS Capital • Newsfile • 10/08/2025 01:30:00 PM
- Form 15-12G/A - Securities registration termination [Section 12(g)]: [Amend] • Edgar (US Regulatory) • 07/22/2025 05:22:28 PM
- Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend] • Edgar (US Regulatory) • 07/07/2025 05:36:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 06/16/2025 08:28:57 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 06/10/2025 03:41:27 PM
